BROADCASTS.com

In his weekly clinical update Dr. Griffin discusses\xa0Tecovirimat for treatment of monkeypox, the safety and acceptance of vaccination after multisystem inflammatory syndrome, variants in solid organ transplant recipients, masks for prevention of respiratory virus infections, pre-exposure prophylaxis with Evusheld, the association between Evusheld administration and infection,\xa0\xa0if\xa0repeat administration of casirivimab and imdevimab is well-tolerated,\xa0viral and symptom rebound in untreated infection,\xa0extended Remdesivir infusion for persistent infection, Baricitinib in patients admitted with infection, and cognitive impairment 13 months after hospitalization.

Subscribe (free):\xa0Apple Podcasts,\xa0Google Podcasts,\xa0RSS,\xa0email

Become a\xa0patron\xa0of\xa0TWiV!

• Armchair Expert with Malcolm Gladwell
• Tecovirimat\xa0for treatment of monkeypox (OFID)
• Safety and acceptance of vaccination after\xa0MIS\xa0(JPID)
• Is variant\xa0less virulent\xa0in solid organ transplant recipients (Transplant Infectious Disease)
• Masks for prevention of\xa0respiratory virus infections\xa0(Annals of Internal Medicine)
• Pre-exposure prophylaxis\xa0with Evusheld (CMI)
• Association between\xa0Evusheld administration and infection\xa0(CID)
• Repeat administration\xa0of casirivimab and imdevimab well-tolerated (ISID)
• PAXLOVID patient eligibility\xa0screening checklist (FDA)
• Remdesivir fact sheet\xa0for providers (Veklury)\xa0
• Bebtelovimab fact sheet\xa0for providers (FDA)
• Viral and symptom rebound in\xa0untreated infection\xa0(medRxiv)
• Extended Remdesivir infusion\xa0for persistent infection (OFID)
• Baricitinib\xa0in patients admitted with infection (The Lancet)
• Cognitive Impairment 13 months after\xa0hospitalization\xa0(OFID)
• Contribute to\xa0Floating Doctors fundraiser at PWB
• Dr. Griffin\u2019s treatment guide (pdf)
• Letters read\xa0on TWiV 924
• Timestamps by Jolene. Thanks!

Intro music is by\xa0Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv